| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Robin James Scott Cridland, Derek McAllan |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 4.30p |
| Change Today | -0.20p |
| % Change | -4.44 % |
| 52 Week High | 4.80 |
| 52 Week Low | 2.10 |
| Volume | 1,227,610 |
| Shares Issued | 533.35m |
| Market Cap | £22.93m |
| Beta | 0.44 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:58 | 3,414 @ 4.39p |
| 15:40 | 75,000 @ 4.30p |
| 15:39 | 46,518 @ 4.31p |
| 15:37 | 20,984 @ 4.31p |
| 15:17 | 6,920 @ 4.34p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research